Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular alterations in pituitary tumors

A Spada1, L Vallar, G Faglia

  • 1Institute of Endocrine Sciences, Ospedale Maggiore IRCCS, Milan, Italy.

European Journal of Endocrinology
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells.

Oncogene·2025
Same author

The Impact of Education and Culture on Poverty Reduction: Evidence from Panel Data of European Countries.

Social indicators research·2023
Same author

Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1-84) treatment.

Journal of endocrinological investigation·2022
Same author

Spine Bone Texture Assessed by Trabecular Bone Score in Active and Controlled Acromegaly: A Prospective Study.

Journal of the Endocrine Society·2021
Same author

Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion.

Molecular and cellular endocrinology·2020
Same author

The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells.

Cancer letters·2020

Molecular studies reveal pituitary adenomas originate from the pituitary gland, with genetic alterations like mutations in Gs alpha-subunit and ras genes driving tumor growth. Further research is needed to understand these complex genetic changes.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Pituitary adenomas are primarily of pituitary origin.
  • Monoclonal origin suggests genomic alterations, but these are found in a minority of tumors.
  • Genetic abnormalities in tumor suppressors (p53, retinoblastoma) are not evident, but chromosome 11q13 loss is seen in some GH-secreting adenomas.

Purpose of the Study:

  • To investigate the molecular basis of pituitary adenomas.
  • To identify specific genetic alterations driving tumor formation and growth.
  • To explore the role of oncogenes and anti-oncogenes in pituitary tumorigenesis.

Main Methods:

  • Molecular studies analyzing genomic alterations.
  • Detection of gene mutations and rearrangements.

Related Experiment Videos

  • Analysis of chromosome abnormalities.

    • Main Results:

    • Activating mutations in the Gs alpha-subunit gene are prevalent in GH-secreting adenomas.
    • Ras gene mutations are identified in invasive pituitary tumors.
    • Loss of chromosome 11q13 sequences, potentially involving the MEN-1 gene, is observed in some GH-secreting adenomas.

    Conclusions:

    • Specific oncogene activations (Gs alpha-subunit, ras) play a role in pituitary adenoma development.
    • Alterations in hypothalamic neurohormone signaling pathways may promote the growth of genetically altered pituitary cells.
    • Understanding these molecular mechanisms is crucial for targeted therapies.